Análisis de terceros
La transparencia no es opcional: publicamos el COA de cada lote.
| Producto | N.º de lote | Pureza | Fecha de análisis |
|---|---|---|---|
| BPC-157 Cápsulas | Novalabs-2026-0028 | 99.2% | 2026-09-05 |
| Oxitocina | Novalabs-2026-0301 | 99.2% | 2026-09-05 |
| N-Acetyl Selank / Semax Intranasal | Novalabs-2026-0210 | 99.0% | 2026-09-05 |
| Epitalón | Novalabs-2026-0126 | 99.0% | 2026-09-03 |
| Kisspeptina-10 | Novalabs-2026-0294 | 99.0% | 2026-09-02 |
| PT-141 Intranasal | Novalabs-2026-0280 | 99.1% | 2026-08-30 |
| BPC-157 / TB-500 (Wolverine) | Novalabs-2026-0014 | 99.2% | 2026-08-25 |
| Tesofensina Cápsulas | Novalabs-2026-0091 | 98.8% | 2026-08-24 |
| PT-141 | Novalabs-2026-0273 | 99.1% | 2026-08-21 |
| SS-31 | Novalabs-2026-0147 | 99.0% | 2026-08-20 |
| Enclomifeno Cápsulas | Novalabs-HRM-ENCLO-12.5MG-CAP-001 | 98.7% | 2026-08-18 |
| Tirzepatida | Novalabs-MET-TIRZ-60 | 99.8% | 2026-08-18 |
| Retatrutida | Novalabs-MET-RET-10 | 99.9% | 2026-08-18 |
| GHK-Cu / KPV (Beauty Blend) | Novalabs-LNG-GHKCUKPV-5020 | 99.6% | 2026-08-18 |
| Oxitocina | Novalabs-HRM-OXY-10 | 99.0% | 2026-08-18 |
| IGF-1 LR3 | Novalabs-GRW-IGF1LR3-1 | 99.6% | 2026-08-18 |
| Retatrutida | Novalabs-MET-RET-30 | 99.7% | 2026-08-18 |
| Tesofensina Cápsulas | Novalabs-MET-TESO-250MCG-CAP-001 | 98.8% | 2026-08-18 |
| Kisspeptina-10 | Novalabs-HRM-KISS-10 | 99.0% | 2026-08-18 |
| Tirzepatida | Novalabs-2026-0049 | 99.3% | 2026-08-12 |